Impairing the interaction between Erg11 and cytochrome P450 reductase Ncp1 enhances azoles' antifungal activities. [PDF]
Li W +5 more
europepmc +1 more source
Antifungal Susceptibility and Resistance-Associated Gene Expression in Nosocomial <i>Candida</i> Isolates. [PDF]
Hernandez-Reyes FB +7 more
europepmc +1 more source
Inter-Hospital Spread of Fluconazole-Resistant C. parapsilosis in Northern Italy: Insights Into Clonal Distribution, Resistance Mechanisms and Biofilm Production. [PDF]
Palladini G +12 more
europepmc +1 more source
First Report of <i>Cystobasidium slooffiae</i> in Human Wounds from China: Molecular Identification and Clinical Insights. [PDF]
Huang J +11 more
europepmc +1 more source
The azole-resistance phenotype of a <i>Nakaseomyces glabratus</i> clinical strain encoding a wild-type <i>PDR1</i> allele involves the efflux pumps Aus1 and Pdh1 and Cyb5, an alternative reductase required for ergosterol biosynthesis. [PDF]
Pinheiro MJ +4 more
europepmc +1 more source
Emerging antifungal resistance in Candida parapsilosis: the end of the innocence. [PDF]
Guinea J +4 more
europepmc +1 more source
Genomic Insights of <i>Candida krusei</i>, an Emerging Fungal Pathogen With Intrinsic Antifungal Resistance. [PDF]
Jain K +5 more
europepmc +1 more source
Phenotypic and genomic characterization of azole resistance in Portuguese <i>Candida parapsilosis</i> isolates. [PDF]
Papuc AM +6 more
europepmc +1 more source
Chitosan nanoparticles loaded with ribavirin, carboplatin, and thyme oil downregulate SNQ2, ERG11, CDR1, and MDR1 in Candida strains. [PDF]
Aghaei S +4 more
europepmc +1 more source
A quiet but growing threat: Global perspectives on antifungal resistance and future therapeutic approaches. [PDF]
Gurajala S, Challapilla M.
europepmc +1 more source

